A regimen consisting of vinorelbine, cyclophosphamide, and capecitabine can outperform paclitaxel in ER+, HER2- metastatic breast cancer, a phase 2 trial suggests.
Leah Lawrence
Leah Lawrence is a freelance health writer and editor based in Delaware. She has contributed to trade, consumer, and medical association publications and websites focused on hematology/oncology, cardiology, primary care, endocrinology, and general health.
